These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 15526241

  • 1. Conclusions on the management of heart failure.
    Swedberg K.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
    [Abstract] [Full Text] [Related]

  • 2. Reassessing guidelines for heart failure.
    Drexler H, Wollert KC.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S28-33. PubMed ID: 15526240
    [Abstract] [Full Text] [Related]

  • 3. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 4. Cellular basis for therapeutic choices in heart failure.
    Opie LH.
    Circulation; 2004 Oct 26; 110(17):2559-61. PubMed ID: 15505109
    [No Abstract] [Full Text] [Related]

  • 5. The HF epidemic: the need for new treatment strategies.
    Carson PE.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun 26; 1(2 Suppl):S32-4. PubMed ID: 17199218
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic therapies across the continuum of left ventricular dysfunction.
    Abraham WT, Greenberg BH, Yancy CW.
    Am J Cardiol; 2008 Sep 08; 102(5A):21G-28G. PubMed ID: 18722188
    [Abstract] [Full Text] [Related]

  • 7. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP.
    Cardiol Rev; 2006 Sep 08; 14(2):81-7. PubMed ID: 16493245
    [Abstract] [Full Text] [Related]

  • 8. Filling the gap between guidelines and clinical practice in heart failure treatment: still a far cry from reality.
    Remme WJ.
    Eur J Heart Fail; 2007 Dec 08; 9(12):1143-5. PubMed ID: 17936067
    [No Abstract] [Full Text] [Related]

  • 9. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan 08; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 10. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

  • 11. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
    Shah NC, Pringle S, Struthers A.
    J Renin Angiotensin Aldosterone Syst; 2006 Mar 16; 7(1):20-30. PubMed ID: 17083070
    [Abstract] [Full Text] [Related]

  • 12. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN, Mareev VIu, Skvortsov AA.
    Ter Arkh; 2008 Mar 16; 80(9):5-12. PubMed ID: 19555028
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 16; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 16. [The defibrillator is not a comprehensive healing method].
    Stiefelhagen P.
    MMW Fortschr Med; 2006 Aug 03; 148(31-32):14. PubMed ID: 16938917
    [No Abstract] [Full Text] [Related]

  • 17. [Antiarrhythmic drug therapy in patients with heart failure].
    Nakamura K, Nishii N, Ohe T.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():369-74. PubMed ID: 17571408
    [No Abstract] [Full Text] [Related]

  • 18. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R, Borelli G, Coceani M, Zingaro S, Barison A, Morelli I, Rondinini L.
    J Clin Pharm Ther; 2008 Aug 28; 33(4):349-56. PubMed ID: 18613852
    [Abstract] [Full Text] [Related]

  • 19. Diastolic heart failure: state of the science on best treatment practices.
    Reddersen LA, Keen C, Nasir L, Berry D.
    J Am Acad Nurse Pract; 2008 Oct 28; 20(10):506-14. PubMed ID: 19128346
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 28; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.